Although Lp(a) concentration measurement and isoform determination are sufficient assays to estimate CAD risk encoded at the LPA locus,49 polygenic risk scores might play an additional role in the assessment of CAD risk in the future.5 This evidence concerns the gene LPA and coronary artery disorder.